Agios Pharmaceuticals, Inc.
AGIO
$33.18
$0.591.81%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 10.10% | -11.00% | -11.93% | -110.91% | -16.54% |
| Total Depreciation and Amortization | 7.23% | 6.65% | -7.39% | 2.16% | -20.97% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 69.87% | 35.31% | 83.64% | 101.31% | 114.66% |
| Change in Net Operating Assets | -112.40% | -6.28% | 90.08% | -100.51% | -18.18% |
| Cash from Operations | 25.69% | -6.67% | 27.75% | -4.67% | -6.25% |
| Capital Expenditure | -38.51% | -0.39% | -15.82% | -271.12% | -453.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -48.12% | 25.34% | 289.24% | 89.62% | 113.47% |
| Cash from Investing | -49.08% | 25.51% | 283.24% | -61.90% | 112.02% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4,744.62% | 28.35% | -47.19% | 68.18% | -94.09% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 4,744.62% | 28.35% | -47.19% | 68.18% | -94.09% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -831.67% | 800.63% | 97.98% | -93.00% | 105.57% |